Acute 'binge' cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice

Brain Research

Volumn 974, Issue 1-2, 2003, Pages 249-253

  Schlussman, Stefan D ^a   Zhang, Yong ^a   Yuferov, Vadim ^a   LaForge, K Steven ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cocaine; Mouse; Preprodynorphin mRNA; Strain difference; Striatum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE; DYNORPHIN; MESSENGER RNA; PREPRODYNORPHIN;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; STEREOTYPY; STRAIN DIFFERENCE;

EID: 0038665273     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02561-7     Document Type: Article

References (47)

1. Banbury Conference on Genetic Background in Mice. Mutant mice and neuroscience: recommendations concerning genetic background. Neuron. 19:1997;755-759.
2. Cabib S., Castellano C., Cestari V., Filibeck U., Puglisi-Allegra S. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology. 105:1991;335-339.
3. Carta A.R., Gerfen C.R., Steiner H. Cocaine effects on gene regulation in the striatum and behavior: increased sensitivity in D3 dopamine receptor-deficient mice. Neuroreport. 11:2000;2395-2399.
4. Daunais J.B., McGinty J.F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res. Mol. Brain Res. 29:1995;201-210.
5. 2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35:1996;237-248.
6. Daunais J.B., Roberts D.C., McGinty J.F. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport. 4:1993;543-546.
7. Devine D.P., Leone P., Pocock D., Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266:1993;1236-1246.
8. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
9. Drago J., Gerfen C.R., Westphal H., Steiner H. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience. 74:1996;813-823.
10. Filibeck U., Cabib S., Castellano C., Puglisi-Allegra S. Chronic cocaine enhances defensive behaviour in the laboratory mouse: involvement of D2 dopamine receptors. Psychopharmacology. 96:1988;437-441.
11. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
12. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
13. Henricks K.K., Miner L.L., Marley R.J. Differential cocaine sensitivity between two closely related substrains of C57BL mice. Psychopharmacology. 132:1997;161-168.
14. Hurd Y.L., Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res. Mol. Brain Res. 16:1992;97-104.
15. Hurd Y.L., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
16. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res. Mol. Brain Res. 13:1992;165-170.
17. Jiang H.K., McGinty J.F., Hong J.S. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 507:1990;57-64.
18. Kreek M.J., LaForge K.S., Butelman E.R. Pharmacotherapy of addictions. Nat. Rev. Drug Discovery. 1:2002;710-726.
19. Kreek M.J., Schluger J., Borg L., Gunduz M., Ho A. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid mediated receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions. J. Pharmacol. Exp. Ther. 288:1999;260-269.
20. Kuzmin A., Johansson B., Fredholm B., Ogren S.O. Genetic evidence that cocaine and caffeine stimulate locomotion in mice via different mechanisms. Life Sci. 66:1999;PL113-PL118.
21. Maisonneuve I.M., Archer S., Glick S.D. U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181:1994;57-60.
22. Miner L.L. Cocaine reward and locomotor activity in C57BL/6J and 129/SvJ inbred mice and their F1 cross. Pharmacol. Biochem. Behav. 58:2000;25-30.
23. Neisewander J.L., Fuchs R.A., O'Dell L.E., Khroyan T.V. Effect of SCH-23390 on dopamine D1 receptor occupancy and locomotion induced by intraaccumbens cocaine infusion. Synapse. 30:1998;194-204.
24. Perret G., Schluger J.H., Unterwald E.M., Kreuter J., Ho A., Kreek M.J. Downregulation of 5-HT1A receptors in rat hypothalamus and dentate gyrus after 'binge' pattern cocaine administration. Synapse. 30:1998;166-171.
25. Quinones-Jenab V., Ho A., Schlussman S.D., Franck J., Kreek M.J. Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav. Brain Res. 101:1999;15-20.
26. Ruth J.A., Ullman E.A., Collins A.C. An analysis of cocaine effects on locomotor activities and heart rates in four inbred mouse strains. Pharmacol. Biochem. Behav. 29:1988;157-162.
27. Schlussman S.D., Ho A., Zhou Y., Curtis A.E., Kreek M.J. Effects of 'binge' pattern cocaine on stereotypy and locomotor activity in C57BL/6J and 129/J mice. Pharmacol. Biochem. Behav. 60:1998;593-599.
28. 1 receptors after chronic "binge" cocaine in 57BL/6J and 129/J mice, Pharmacol. Biochem. Behav., in press.
29. Schlussman S.D., Zhou Y., Johansson P., Kiuru A., Ho A., Nyberg F., Kreek M.J. Effects of the androgenic anabolic steroid, nandrolone decanoate, on adrenocorticotropin hormone, corticosterone and proopiomelanocortin, corticotropin releasing factor (CRF) and CRF receptor1 mRNA levels in the hypothalamus, pituitary and amygdala of the rat. Neurosci. Lett. 284:2000;190-194.
30. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
31. Spangler R., Unterwald E.M., Kreek M.J. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res. Mol. Brain Res. 19:1993;323-327.
32. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., Kreek M.J. Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. Neuroreport. 7:1996;2196-2200.
33. Spangler R., Zhou Y., Maggos C.E., Schlussman S.D., Ho A., Kreek M.J. Prodynorphin, proenkephalin and kappa opioid receptor mRNA responses to acute 'binge' cocaine. Brain Res. Mol. Brain Res. 44:1997;139-142.
34. Steiner H., Gerfen C.R. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. Comp. Neurol. 353:1995;200-212.
35. Steiner H., Gerfen C.R. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J. Comp. Neurol. 376:1996;530-541.
36. 1 dopamine receptor messenger RNAs during cocaine abstinence. Mol. Brain Res. 56:1998;162-168.
37. Tella S.R. Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48:1994;151-159.
38. Tolliver B.K., Carney J.M. Comparison of cocaine and GBR 12935: effects on locomotor activity and stereotypy in two inbred mouse strains. Pharmacol. Biochem. Behav. 48:1994;733-739.
39. Unterwald E.M., Ho A., Rubenfeld J.M., Kreek M.J. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J. Pharmacol. Exp. Ther. 270:1994;1387-1396.
40. Womer D.E., Jones B.C., Erwin V.G. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice. Pharmacol. Biochem. Behav. 48:1994;327-335.
41. Xu M., Hu X.T., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 79:1994;945-955.
42. Yuferov V., Zhou Y., LaForge K.S., Spangler R., Ho A., Kreek M.J. Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by 'binge' pattern cocaine administration. Brain Res. Bull. 55:2001;65-70.
43. Zhang Y., Schlussman S.D., Ho A., Kreek M.J. Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice. Brain Res. 921:2001;172-177.
44. Zhang Y., Butelman E.R., Schlussman S.D., Ho A., Kreek M.J. Effect of an endogenous opioid agonist, dynorphin (1-17), on extracellular dopamine levels in the caudate putamen of C57BL/6J mice. 2002;Society for Neuroscience, Washington, DC. online, 2002.
45. Zhang Y., Mantsch J.R., Schlussman S.D., Ho A., Kreek M.J. Conditioned place preference after single doses or 'binge' cocaine in C57BL/6J and 129/J mice. Pharmacol. Biochem. Behav. 73:2002;655-662.
46. Zhou Y., Schlussman S.D., Ho A., Spangler R., Fienberg A.A., Greengard P., Kreek M.J. Effects of chronic 'binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. Neuroendocrinology. 70:1999;196-199.
47. Zhou Y., Spangler R., Schlussman S.D., Yuferov V., Sora I., Ho A., Uhl G.R., Kreek M.J. Effects of acute 'binge' cocaine on preprodynorphin, preproenkephalin, and corticotropin releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice. Synapse. 45:2002;220-229.